Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure

Last updated: July 26, 2024
Sponsor: East and North Hertfordshire NHS Trust
Overall Status: Active - Recruiting

Phase

N/A

Condition

Chest Pain

Hyponatremia

Heart Failure

Treatment

HF-guided VA

Standard-of-care

Clinical Study ID

NCT06400927
RD2024-10
  • Ages > 18
  • All Genders

Study Summary

The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥ 18 years

  • Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge

Exclusion Criteria

  • Known prior history of HF

  • Severe comorbidities that could affect protocol adherence, in the opinion of the investigator

  • Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease

  • Dementia or other cognitive impairment

  • Currently involved in another interventional clinical trial

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: HF-guided VA
Phase:
Study Start date:
May 07, 2024
Estimated Completion Date:
September 13, 2027

Connect with a study center

  • East and North Hertfordshire NHS Trust

    Stevenage, Hertfordshire SG1 4AB
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.